Drug Information

General Information
Drug ID
DR00204
Drug Name
Ponatinib
Synonyms
Iclusig (TN)
Drug Type
Small molecular drug
Indication Acute lymphoblastic leukemia [ICD11: 2B33.0] Approved [1]
Structure
3D MOL 2D MOL
Formula
C29H27F3N6O
Canonical SMILES
CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5
InChI
InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)
InChIKey
PHXJVRSECIGDHY-UHFFFAOYSA-N
CAS Number
CAS 943319-70-8
Pharmaceutical Properties Molecular Weight 532.6 Topological Polar Surface Area 65.8
Heavy Atom Count 39 Rotatable Bond Count 6
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 8
XLogP
4.1
PubChem CID
24826799
PubChem SID
103162345 , 103768137 , 104144064 , 124757292 , 125164096 , 131480900 , 135263267 , 135626676 , 135727465 , 136350016 , 136367447 , 136368095 , 136920265 , 137245313 , 137275996 , 139832791 , 144115614 , 152134633 , 152146116 , 152258369 , 160644559 , 160647206 , 162011539 , 162037632 , 162164010 , 162164012 , 162201514 , 163209942 , 164043013 , 164187223 , 164834148 , 170503740 , 172087035 , 174006583 , 174531620 , 175266091 , 175427142 , 177749778 , 178102513 , 180371706 , 185988972 , 188899573 , 196408591 , 198993325 , 204380154 , 49848164 , 57136216 , 85267726 , 85267727 , 99437188
ChEBI ID
ChEBI:78543
TTD Drug ID
D0H0EQ
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Ponatinib was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. (ID: DB08901)

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.